ReleaseWire Connect

Quantum dots are semiconducting nanoparticles that range from 1nm to 10nm diameter in size and demonstrate quantum mechanical properties. The peculiarity of quantum dots is that they have ability to unite their semiconductor properties with those of nanomaterials. In addition, tunable nanocrystal size and superior optical properties have made quantum dots attractive semiconducting material for variety of applications in the field of healthcare, optoelectronics, solar energy, and security among others.

Organ transplantation involves surgical removal and transfer of a healthy organ from a living or dead human body into another individual's body. Often, it is the only treatment for end stage organ failure. Use of immunosuppressant drugs post organ transplantation procedures has increased the success rate of organ transplants. Excess demand coupled with shortage of organ donors and procedural difficulties leads to different waiting time and success rates for organ transplantation. The global organ transplant immunosuppressant drugs market was valued at USD 5,139.7 million in 2014 and is expected to reach USD 3,234.8 million by 2023, declining at a CAGR of - (5.0)% during the forecast period 2015 to 2023.

Nanosilver are silver particles ranging from 1nm to 100nm in size. Currently, nanosilver particles are used in a variety of applications. These include electronics, cosmetics, medical, pharmaceutical, pesticides, textiles, plastics, paints & coatings, water treatment, food & beverages, packaging, and detergents. Small particle size, large surface area, less loading of silver, and excellent antibacterial and conductive properties are the major advantages of nanosilver. Silver nitrate along with other silver salts such as silver sulfate, silver acetate, sodium borohydride and silver oxide is employed in the manufacture of nanosilver depending upon the size and the geometry of the nanosilver particle. Based on product type, nanosilver is available in powder, colloidal, and master batch forms.

Molded plastics are formed or molded products made of polymers or as they are commonly known, plastics. Molded plastics are products that are produced using molds or casts to give the raw material a desired shape. The technologies used for molding plastics include injection molding, blow molding, thermoforming, rotomolding, casting and profile extrusion among others. Molded plastics are primarily utilized in construction, packaging, automotive, furniture, medical, electronics, and consumer goods industries. Molded plastics offer the advantage of developing products and solutions that are lighter and inert. These are typically used as effective substitutes for metal, wood and paper. In addition to inertness and light weight, molded plastics enable shorter process time, which can be attributed to their easy handling and molding technologies. Technologies such as injection molding, profile extrusion and thermoforming enable fast production of molded plastic products in a wide variety of shapes. This has helped applications, especially in packaging and construction industries, to achieve time and cost benefits that are purely attributed to fast process time.

The rise in geriatric population throughout the globe is contributing greatly to the increasing number of various minimally invasive surgeries (MIS) such as breast, orthopedic, cardiac, gynecological and urological surgeries.This is mainly because, elderly people belong to the high risk patient category for performing conventional open surgeries due to their already compromised health and slow recovery from debilitating conditions. MIS is performed with a tiny incision in the patient's body that results in faster recovery, minimal stay in the hospital, and minimal pain and trauma to the patient. These surgeries are performed with the help of various devices that include surgical devices, monitoring and visualization devices, and endoscopy devices.The overall global market for minimally invasive surgery is expected to grow at a CAGR of 10.5% from 2013 to 2019 to reach an estimated value of USD 50.60 billion in 2019.

Rising water scarcity and need to enhance crop productivity has led to the demand for efficient irrigation methods such as micro irrigation. Micro irrigation systems are expected to witness high demand during the forecast period owing to the wide advantages of these systems over conventional irrigation systems. Micro irrigation systems offer high efficiency and accurate application of water to plants. In addition, micro irrigation systems help in significantly reducing the water wastage as water is directly supplied to the plant root rather than the whole field. This is one of the most important factors responsible for growing adoption of micro irrigation systems in different applications across the world.

Latin America industrial refrigeration equipment market was valued at USD 431.8 million in 2012 and is expected to see growth at 6.5% CAGR from 2013 to 2019. Industrial refrigeration systems play crucial role in the business operations of companies across industries, such as food and beverage processing, cold storage warehousing, and chemical processing, among others, which require temperature controlled handling of raw materials, in-process materials, and finished goods. Maintaining temperature at desired levels is critical to ensure desired quality of materials throughout the prescribed use time (best before or expiry date). Changing food consumption trends and increased international trade of food products, which require refrigeration, are some of the key factors which are currently driving the industrial refrigeration industry in Latin America.

Dyslipidemia is a chronic metabolic disease, characterized by abnormal amount of low density lipoprotein, high density lipoprotein and triglyceride levels. Abnormal lipid level is also one of the major risk factor for the cardiovascular diseases such as atherosclerosis, hypertension and others. The range of therapeutics which includes statins, bile acid resins, cholesterol absorption inhibitors, fibric acid derivatives, omega-3 fatty acid derivatives and niacins are used for the treatment and mitigation of dyslipidemia disorder. Additionally, combination therapies such as statin and fibric acid analogs, ezetimibe and statins (Vytorin), niacins and statins (Advicor) and others are also used for effective treatment of dyslipidemia. Increasing incidences of dyslipidemia in developed (i.e. North America and Europe) and developing (i.e. Asia Pacific and Latin America) regions coupled with rising number of prescription for drugs such as statins and fibric acid derivatives drives the dyslipidemia drugs market growth. However, increase in the number of year on year patent expirations of blockbuster drugs such as Lipitor, Vytorin, Zetia and Crestor is expected to hamper the growth of dyslipidemia drugs market. This market was valued at USD 17,858.3 million in 2014 and is projected to contract at a CAGR of -10.3% from 2015 to 2023 to reach USD 6,888.9 million by 2023.

According to the U.S. Food and Drug Administration, drug device combination products are defined as therapeutic products comprising an active pharmaceutical ingredient and a medical device that are physically and/or chemically, combined to be produced as a single product. The drug present in the device may be impregnated or surface coated. Such products can be designed for local as well as systemic administration of drug to the patient. Recently, combination products are emerging as innovative medical products due to their contribution in advancing medical care and are thus expected to have major impact in the coming years.

U.S. commercial air conditioning systems market was valued at USD 7,251.7 million in 2012 and is expected to see growth at 5.2% CAGR during 2013 to 2019 period. With developments in technology and growing demand across the globe, the air conditioning systems market is predicted to experience healthy growth in the coming years. The growth of the U.S. commercial air conditioning systems market is supported by stringent government regulations and development of cost effective and energy efficient products.